Thyrocare Technologies Limited (THYROCARE.BO)

INR 980.85

(-1.19%)

Long Term Debt Summary of Thyrocare Technologies Limited

Thyrocare Technologies Limited's latest annual long term debt in 2023 was 109.1 Million INR , down -32.32% from previous year.
Thyrocare Technologies Limited's latest quarterly long term debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
Thyrocare Technologies Limited reported annual long term debt of 161.2 Million INR in 2022, up 2.68% from previous year.
Thyrocare Technologies Limited reported annual long term debt of 157 Million INR in 2021, up 188.07% from previous year.
Thyrocare Technologies Limited reported quarterly long term debt of - INR for 2024 Q2, down 0.0% from previous quarter.
Thyrocare Technologies Limited reported quarterly long term debt of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Thyrocare Technologies Limited (2023 - 2012)

Historical Annual Long Term Debt of Thyrocare Technologies Limited (2023 - 2012)

Year	Long Term Debt	Long Term Debt Growth
2023	109.1 Million INR	-32.32%
2022	161.2 Million INR	2.68%
2021	157 Million INR	188.07%
2020	54.5 Million INR	-33.46%
2019	81.9 Million INR	227.6%
2018	25 Million INR	135.41%
2017	-70.61 Million INR	-197.39%
2016	72.5 Million INR	31.79%
2015	55.01 Million INR	0.0%
2014	- INR	-100.0%
2013	250 Million INR	0.0%
2012	250 Million INR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	- INR	-100.0%
2024 Q2	- INR	0.0%
2023 Q1	- INR	-100.0%
2023 Q3	- INR	-100.0%
2023 Q2	307.5 Million INR	0.0%
2023 FY	109.1 Million INR	-32.32%
2023 Q4	109.1 Million INR	0.0%
2022 Q3	135.9 Million INR	16.25%
2022 Q1	- INR	-100.0%
2022 Q2	116.9 Million INR	0.0%
2022 FY	161.2 Million INR	2.68%
2022 Q4	161.2 Million INR	18.62%
2021 Q4	157 Million INR	-8.72%
2021 FY	157 Million INR	188.07%
2021 Q2	179.5 Million INR	-17.05%
2021 Q1	216.4 Million INR	297.06%
2021 Q3	172 Million INR	-4.18%
2020 Q2	116.9 Million INR	0.0%
2020 Q1	- INR	-100.0%
2020 Q3	- INR	-100.0%
2020 Q4	54.5 Million INR	0.0%
2020 FY	54.5 Million INR	-33.46%
2019 Q1	- INR	-100.0%
2019 FY	81.9 Million INR	227.6%
2019 Q4	81.9 Million INR	0.0%
2019 Q2	138.8 Million INR	0.0%
2019 Q3	- INR	-100.0%
2018 Q2	99.3 Million INR	0.0%
2018 FY	25 Million INR	135.41%
2018 Q1	- INR	0.0%
2018 Q4	25 Million INR	0.0%
2018 Q3	- INR	-100.0%
2017 Q2	92.52 Million INR	0.0%
2017 Q3	- INR	-100.0%
2017 Q4	- INR	0.0%
2017 FY	-70.61 Million INR	-197.39%
2017 Q1	- INR	-100.0%
2016 Q3	- INR	0.0%
2016 Q2	- INR	0.0%
2016 Q1	- INR	-100.0%
2016 FY	72.5 Million INR	31.79%
2016 Q4	72.5 Million INR	0.0%
2015 Q3	- INR	0.0%
2015 Q1	- INR	0.0%
2015 FY	55.01 Million INR	0.0%
2015 Q4	55.01 Million INR	0.0%
2015 Q2	- INR	0.0%
2014 FY	- INR	-100.0%
2013 FY	250 Million INR	0.0%
2012 FY	250 Million INR	0.0%

Peer Long Term Debt Comparison of Thyrocare Technologies Limited

Name	Long Term Debt	Long Term Debt Difference
Krsnaa Diagnostics Limited	55 Million INR	-98.364%
Dr. Lal PathLabs Limited	1.03 Billion INR	89.408%
Metropolis Healthcare Limited	1.19 Billion INR	90.837%
Vijaya Diagnostic Centre Limited	2.39 Billion INR	95.436%
Vimta Labs Limited	90.74 Million INR	-20.234%